Allstate Corp Bio Rad Laboratories, Inc. Transaction History
Allstate Corp
- $3.33 Billion
- Q4 2024
A detailed history of Allstate Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Allstate Corp holds 621 shares of BIO stock, worth $172,116. This represents 0.01% of its overall portfolio holdings.
Number of Shares
621Holding current value
$172,116% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding BIO
# of Institutions
480Shares Held
19.6MCall Options Held
15.5KPut Options Held
12.3K-
Vanguard Group Inc Valley Forge, PA1.92MShares$532 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$430 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$289 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$271 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$207 Million0.06% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.83B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...